Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.25
+0.03 (0.40%)
At close: Jun 12, 2025, 4:00 PM
6.35
+0.10 (1.63%)
After-hours: Jun 12, 2025, 4:47 PM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
n/a
Profits / Employee
-$324,890
Market Cap
319.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ABEO News
- 7 days ago - Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade) - Seeking Alpha
- 10 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 27 days ago - Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 4 weeks ago - UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder - GlobeNewsWire